Biotech

All Articles

Novo inks $600M NanoVation bargain to research genetic medications ex-liver

.Novo Nordisk is actually proceeding its press right into genetic medications, agreeing to compensat...

Innovent hyperlinks cytokine to colon cancer cells actions

.Innovent Biologics has helped make the instance that its own gate inhibitor-cytokine blend healthy ...

Merck, Daiichi ADC hits target in phase 3 lung cancer study

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina strengthens artificial intelligence center with collab to pick cancer aim ats

.Five months after Rakovina Therapeutics pivoted towards artificial intelligence, the cancer-focused...

Ascendis' dwarfism medicine smash hits in period 3, endangers BioMarin

.Ascendis Pharma has become a potential risk to BioMarin's Voxzogo, reporting phase 3 development di...

Despite ph. 3 overlook, Alkeus sees road in advance for eye disease property

.Though Alkeus Pharmaceuticals' dental eye disease property neglected to dramatically reduce geograp...

Kairos goes public along with $6M IPO to cash trials of cancer cells drug

.Along with a triad of biotechs striking the Nasdaq on Friday, it was very easy to miss a smaller-sc...

Vaccine as well as Keytruda combination efficient in squamous cell carcinoma

.Invulnerable checkpoint preventions are actually the superheroes of cancer cells treatment. Drugs l...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as ...

Regeneron's Opdualag rival presents 57% reaction rate

.Regeneron is back along with lasting consequence for its own LAG-3 prevention and PD-1 prevention c...